Search Results

Your search for Mylan Inc. in News Releases returned 12 results

News Releases

• May 21, 2013, 14:31 ET

  "Modern Family" Star Julie Bowen Calls on Communities to Raise Their Hand for Anaphylaxis Awareness in Nationwide Competition

  

  As part of the national Get Schooled in Anaphylaxis™ initiative, Emmy®-award winning actress Julie Bowen today kicked off Raise Your Hand for Anaphylaxis Awareness™, a community-driven competition designed to bring attention to the issue of life-threatening allergic reactions, or...

  More news about: Mylan, Inc.

• May 21, 2013, 07:30 ET

  Federal Appellate Court Rules in Favor of Mylan in Patent Infringement Litigation Relating to Sunovion's Brovana® Product

  Mylan Inc. (Nasdaq: MYL) today announced that the Court of Appeals for the Federal Circuit has ruled in favor of Mylan Specialty L.P., f/k/a Dey Pharma, L.P. and has reversed the District Court's decision invalidating five of Mylan's patents related to Perforomist®. The Court's reversal of...

  More news about: Mylan Inc. , Dey Pharma, L.P. , Sunovion , Mylan Specialty L.P.

• May 17, 2013, 07:30 ET

  Mylan Launches Generic Tricor® Tablets

  Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this...

  More news about: Mylan Inc. , Mylan Pharmaceuticals Inc.

• May 15, 2013, 11:40 ET

  Mylan Launches Generic Zomig® Tablets

  Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Zolmitriptan Tablets, 2.5 mg and 5 mg. This product is the generic version of IPR...

  More news about: Mylan Inc. , Mylan Pharmaceuticals Inc.

• May 10, 2013, 11:12 ET

  Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Walk for Food Allergy

  In recognition of Food Allergy Awareness Week, Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), today announced their participation as the national presenting sponsor of the Food Allergy Research & Education (FARE) Walk for Food Allergy....

  More news about: Mylan Specialty L.P. , Food Allergy Research & Education (FARE) , Mylan Inc.

• May 02, 2013, 16:05 ET

  Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62

  Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three months ended March 31, 2013. Financial Highlights - Adjusted diluted EPS of $0.62 for the three months ended March 31, 2013 compared to $0.52 for the same prior year period, an increase of 19% - Total...

  More news about: Mylan Inc.

• Apr 30, 2013, 15:15 ET

  Deborah Autor, FDA's Deputy Commissioner for Global Regulatory Operations and Policy, to Join Mylan

  Mylan Inc. (Nasdaq: MYL) today announced that it has appointed Deborah M. Autor as senior vice president, Strategic Global Quality and Regulatory Policy. Autor joins Mylan from the U.S. Food and Drug Administration (FDA), where she served for 11 years, most recently as deputy commissioner for...

  More news about: Mylan Inc.

• Apr 22, 2013, 08:34 ET

  Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund

  Mylan Inc. (Nasdaq: MYL) today announced that it has contributed $1 million to The Pittsburgh Promise Scholarship Fund, a scholarship program for Pittsburgh Public School students that advocates for improving the quality of education and increasing the preparedness and diversity of the region's...

  More news about: Mylan Inc.

• Apr 09, 2013, 08:00 ET

  Mylan Schedules First Quarter 2013 Financial Results Conference Call and Live Webcast

  Mylan Inc. (Nasdaq: MYL) announced today that it will host a conference call and live webcast Thursday, May 2, 2013, at 4:30 p.m. ET, to review the company's financial results for the first quarter, which ended March 31, 2013. Mylan will release its financial results on May 2 after the market...

  More news about: Mylan Inc.

• Apr 03, 2013, 15:01 ET

  Mylan Launches First Generic Version of Zovirax® Ointment

  Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Acyclovir Ointment USP, 5%. This product is the first generic version of Valeant...

  More news about: Mylan Inc. , Mylan Pharmaceuticals , Valeant International